Prospective associations between plasma saturated, monounsaturated and polyunsaturated fatty acids and overall and breast cancer risk - modulation by antioxidants: A nested case-control study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Pouchieu, Camille ^a   Chajès, Véronique ^b   Laporte, François ^c   Kesse Guyot, Emmanuelle ^a   Galan, Pilar ^a   Hercberg, Serge ^a,d   Latino Martel, Paule ^a   Touvier, Mathilde ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; DIHOMO GAMMA LINOLENIC ACID; MONOUNSATURATED FATTY ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SELENIUM; ZINC;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; TUMOR VOLUME;

ANTIOXIDANTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK;

EID: 84897829835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090442     Document Type: Article

References (49)

1. Pauwels EK, Kairemo K (2008) Fatty acid facts, part II: role in the prevention of carcinogenesis, or, more fish on the dish? Drug News Perspect 21: 504-10.
2. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79: 935-945. (Pubitemid 41095944)
3. Welsch CW (1987) Enhancement of mammary tumorigenesis by dietary fat; review of potential mechanisms. Am J Clin Nutr 45: 192-202.
4. Serini S, Fasano E, Piccioni E, Cittadini ARM, Calviello G (2011) Dietary n-3 Polyunsaturated Fatty Acids and the Paradox of Their Health Benefits and Potential Harmful Effects. Chem Res Toxicol 24: 2093-2105.
5. Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, et al. (2003) Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 362: 212-214. (Pubitemid 36859940)
6. Arab L (2003) Biomarkers of Fat and Fatty Acid Intake. J Nutr 133: 925S-932S.
7. Zock PL, Mensink RP, Harryvan J, de Vries JHM, Katan MB (1997) Fatty Acids in Serum Cholesteryl Esters as Quantitative Biomarkers of Dietary Intake in Humans. Am J Epidemiol 145: 1114-1122. (Pubitemid 27272941)
8. Byers T, Gieseker K (1997) Issues in the design and interpretation of studies of fatty acids and cancer in humans. Am J Clin Nutr 66: 1541S-1547S. (Pubitemid 27518222)
9. Saadatian-Elahi M, Norat T, Goudable Jl, Riboli E (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: A meta-analysis. Int J Cancer 111: 584-591. (Pubitemid 39045326)
10. Pala V, Krogh V, Muti P, Chajès V, Riboli E, et al. (2001) Erythrocyte Membrane Fatty Acids and Subsequent Breast Cancer: a Prospective Italian Study. J Natl Cancer Inst 93: 1088-1095. (Pubitemid 32717541)
11. Chajès V, Hultén K, Van Kappel AL, Winkvist A, Kaaks R, et al. (1999) Fatty-acid composition in serum phospholipids and risk of breast cancer: An incident case-control study in Sweden. Int J Cancer 83: 585-590. (Pubitemid 29508033)
12. Saadatian-Elahi M, Toniolo P, Ferrari P, Goudable J, Akhmedkhanov A, et al. (2002) Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study. IARC Sci Publ 156: 227-30.
13. Takata Y, King I, Neuhouser M, Schaffer S, Barnett M, et al. (2009) Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers. Cancer Causes Control 20: 497-504.
14. Wirfalt E, Vessby B, Mattisson I, Gullberg B, Olsson H, et al. (2004) No relations between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal women of the Malmo Diet Cancer cohort (Sweden). Eur J Clin Nutr 58: 761-770. (Pubitemid 38714463)
15. Rissanen H, Knekt P, Jarvinen R, Salminen I, Hakulinen T (2003) Serum Fatty Acids and Breast Cancer Incidence. Nutr Cancer 45: 168-175. (Pubitemid 37022789)
16. Cheng TYD, King IB, Barnett MJ, Ambrosone CB, Thornquist MD, et al. (2013) Serum Phospholipid Fatty Acids, Genetic Variation in Myeloperoxidase, and Prostate Cancer Risk in Heavy Smokers: A Gene-Nutrient Interaction in the Carotene and Retinol Efficacy Trial. Am J Epidemiol 177: 1106-1117.
17. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, et al. (1994) Prospective Study of Plasma Fatty Acids and Risk of Prostate Cancer. J Natl Cancer Inst 86: 281-286. (Pubitemid 24057406)
18. Brasky TM, Till C, White E, Neuhouser ML, Song X, et al. (2011) Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial. Am J Epidemiol 173: 1429-1439.
19. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, et al. (2007) A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev 16: 1364-1370. (Pubitemid 47076865)
20. Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, et al. (2008) Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88: 1353-1363.
21. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, et al. (1997) Prediagnostic level of fatty acids in serum phospholipids: Om-3 and Om-6 fatty acids and the risk of prostate cancer. Int J Cancer 71: 545-551. (Pubitemid 27239362)
22. Park SY, Wilkens L, Henning S, Le Marchand Lc, Gao K, et al. (2009) Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 20: 211-223.
23. Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, et al. (2011) Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Am J Clin Nutr 94: 1304-1313.
24. Kojima M, Wakai K, Tokudome S, Suzuki K, Tamakoshi K, et al. (2005) Serum Levels of Polyunsaturated Fatty Acids and Risk of Colorectal Cancer: A Prospective Study. Am J Epidemiol 161: 462-471. (Pubitemid 40315617)
25. Colas S, Germain E, Arab K, Maheo K, Goupille C, et al. (2005) a-Tocopherol Suppresses Mammary Tumor Sensitivity to Anthracyclines in Fish Oil-Fed Rats. Nutr Cancer 51: 178-183. (Pubitemid 40734718)
26. Nohl H, Rohr-Udilova N, Gille L, Bieberschulte W, Jurek D, et al. (2005) Suppression of Tumour-promoting Factors in Fat-induced Colon Carcinogenesis by the Antioxidants Caroverine and Ubiquinone. Anticancer Res 25: 2793-2800. (Pubitemid 41044664)
27. Welsch CW (1995) Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free Radic Biol Med 18: 757-73.
28. Verhoeven DTH, Assen N, Goldbohm RA, Dorant E, van 't Veer P, et al. (1997) Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. Br J Cancer 75: 149-155. (Pubitemid 27007289)
29. Michels KB, Holmberg L, Bergkvist L, Ljung H, Bruce A, et al. (2001) Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women. International Journal of Cancer 91: 563-567. (Pubitemid 32115114)
30. Thiébaut ACM, Chajès V, Gerber M, Boutron-Ruault MC, Joulin V, et al. (2009) Dietary intakes of Omega-6 and Omega-3 polyunsaturated fatty acids and the risk of breast cancer. International Journal of Cancer 124: 924-931.
31. Mañnnisto S, Pietinen P, Virtanen MJ, Salminen I, Albanes D, et al. (2003) Fatty Acids and Risk of Prostate Cancer in a Nested Case-Control Study in Male Smokers. Cancer Epidemiol Biomarkers Prev 12: 1422-1428. (Pubitemid 38031744)
32. Nkondjock A, Shatenstein B, Ghadirian P (2003) A case-control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada. Breast 12: 128-135. (Pubitemid 36546437)
33. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, et al. (2004) The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342. (Pubitemid 39532244)
34. WHO (1993) ICD-10, International classification of diseases and related health problems.10th revision.
35. Wang X, Lin H, Gu Y (2012) Multiple roles of dihomo-gamma-linolenic acid against proliferation diseases. Lipids Health Dis 11: 25.
36. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, et al. (2004) Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: A novel mechanism by which dietary fat can alter mammary tumorigenesis. Int J Oncol 24: 1369-1383.
37. Hammarstrom S (1981) Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. J Biol Chem 256: 2275-2279.
38. Jakschik BA, Morrison AR, Sprecher H (1983) Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway. J Biol Chem 258: 12797-12800. (Pubitemid 14237268)
39. Rose DP (1997) Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66: 1513S-1522S.
40. Comba A, Lin YH, Eynard A, Valentich M, Fernandez-Zapico Mn, et al. (2011) Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev 30: 325-342.
41. Simonsen NR, Fernandez-Crehuet Navajas J, Martin-Moreno JM, Strain JJ, et al. (1998) Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Am J Clin Nutr 68: 134-141.
42. Colas S, Mahéo K, Denis F, Goupille C, Hoinard C, Champeroux P, Tranquart F, Bougnoux P (2006) Sensitization by Dietary Docosahexaenoic Acid of Rat Mammary Carcinoma to Anthracycline: A Role for Tumor Vascularization. Clin Cancer Res 12: 5879-5886.
43. Chajès V, Thiébaut ACM, Rotival M, Gauthier E, Maillard V, et al. (2008) Association between Serum trans-Monounsaturated Fatty Acids and Breast Cancer Risk in the E3N-EPIC Study. Am J Epidemiol 167: 1312-1320. (Pubitemid 351770558)
44. Bassett JK, Severi G, Hodge AM, MacInnis RJ, Gibson RA, et al. (2013) Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 133: 1882-1891.
45. Wakil SJ, Stoops JK, Joshi VC (1983) Fatty Acid Synthesis and its Regulation. Annu Rev Biochem 52: 537-579. (Pubitemid 13030689)
46. Food and Agriculture Organization of the United Nations Food and Nutrition (2010) Fats and fatty acids in human nutrition: report of an expert consultation. Paper 91. FAO, Rome.
47. Chajès V, Joulin V, Clavel-Chapelon F (2011) The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk. Curr Opin Lipidol 22: 6-10.
48. Marino M, Ascenzi P (2008) Membrane association of estrogen receptor α and β influences 17 β-estradiol-mediated cancer cell proliferation. Steroids 73: 853- 858.
49. King IB, Kristal AR, Schaffer S, Thornquist M, Goodman GE (2005) Serum Trans-Fatty Acids Are Associated with Risk of Prostate Cancer in b-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 14: 988-992. (Pubitemid 40478568)